10x Genomics xenium Prime Reagents Tender, USA - 119562979

Procurement Summary

Country : USA

Summary : 10x Genomics xenium Prime Reagents

Deadline : 23 May 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 119562979

Document Ref. No. : RFQ-NIAID-25-2261175-(CORRECTION-TO-RFQ-NIAID-25-2251175)

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items, ” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2261175 and the solicitation is issued as a Request for Quotes (RFQ).



This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-3 January 17, 2025.



The North American Industry Classification System (NAICS) code for this procurement is 325414, Biological Product (except Diagnostic) Manufacturing, with a size standard of 1, 250 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside.



The NIH, NIAID, LCIM, has an emergency procurement for spatial transcriptomics of iPSC-derived cerebral organoids and MS human brain tissue. These are necessary supplies for the ongoing research experiments. These items are for an ongoing project utilizing induced pluripotent stem cells (iPSCs) from patients involved in the clinical trial ongoing in the NDS lab to develop cerebral organoids as a translatable and complex biological model for multiple sclerosis (MS). The organoids have been growing and maintained alive for approximately two and a half years. They are currently being cultured with different drugs we study in TRAP-MS clinical trials. To get organoids to this stage cost us thousands of dollars in reagents and in time spent working on this project. The items will ...
Active Contract Opportunity
Notice ID : RFQ-NIAID-25-2261175-(CORRECTION-TO-RFQ-NIAID-25-2251175)
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
Original Published Date: May 21, 2025 10:59 am EDT
Original Date Offers Due: May 23, 2025 10:00 am EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Jun 07, 2025
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance: Bethesda, MD 20892 USA

Documents

 Tender Notice

Award_Terms_and_Conditions_FAR_52.pdf